Pharmaceutical business Amerigen Pharmaceuticals Limited reported on Thursday the availability of its generic bexarotene in 75mg capsules in the US market.

The company said the launch of the generic bexarotene in 75mg capsules follows the approval of its corresponding Abbreviated New Drug Application (ANDA) by the US Food and Drug Administration. The bexarotene capsule is indicated in the treatment of cutaneous t-cell lymphoma

According to the company, the bexarotene product is a generic equivalent to Valeant Pharmaceuticals' Targretin Capsules.

In conjunction, the company's generic bexarotene capsules are marketed by its US affiliate, Amerigen Pharmaceuticals Inc.